BIOLYPH Email Format
Biotechnology ResearchMinnesota, United States11-50 Employees
BIOLYPH is a biotechnology research company based in Chaska, Minnesota, that develops and manufactures systems for stabilizing and delivering lyophilized reagents. Its core offering centers on LyoSpheres™, tiny, precisely formed lyophilized reagent spheres that remain stable in delivery devices until rehydration, enabling incompatible reagents to coexist in a shelf-stable format. The company also markets ReActivator™, a disposable unit-of-use delivery system that combines preportioned lyophilized reagents with diluents for convenient, contaminant-free rehydration. This combination addresses customers’ needs for stable, easy-to-use reagents, particularly in settings requiring reliable shelf-life and precise rehydration, such as diagnostic testing. BIOLYPH serves the biotechnology research space with products designed to simplify reagent handling and improve the practicality of delivering rehydrated reagents at the point of use. In March 2020, the company announced a partnership with XCR Diagnostics to leverage BIOLYPH’s capabilities to enhance the performance and shelf-life of its COVID-19 test, illustrating its active collaboration within the diagnostics field.